Sponsor
Gradalis, Inc.
Clinical research sponsor
How to interpret these research links
Connected source recordsThe exact organization name Gradalis, Inc. appears in 3 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
3 shownVigil™ + Nivolumab in Advanced Non-Small Cell Lung CancerNCT02639234 · lead sponsor · 2016-03-01
WITHDRAWNTrial of Bi-shRNA-furin and GMCSF Augmented Autologous Tumor Cell Vaccine for Advanced CancerNCT01061840 · lead sponsor · 2009-12-01
COMPLETEDPilot Study of Durvalumab and Vigil in Advanced Women's CancersNCT02725489 · collaborator · 2016-06-03
COMPLETEDSponsor roles
lead sponsor2
collaborator1
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.